Breakfast Workshop: Design thinking – how to make an impact in innovation, transformation and patient experience

Design thinking is deployed to get to the heart of complex issues, a step-by-step approach involving a lot of listening to ensure that ideas aren’t just creative but are effective and practical – ultimately ensuring that they get adopted. For healthcare CxOs, now is the perfect time to deploy the process with the sector adopting technology at breakneck speed ensuring the voices of all stakeholders are heard as new products, services and care delivery models are developed.

Join Craig Wills, CEO of Hi Mum! Said Dad (an L.E.K. company) and L.E.K.’s Katya Zubareva, Klaus Boehncke and Jacqueline Thompson for this breakfast at HBI 2024, sharing case studies into successful projects that followed this approach and demonstrating the concept, based on working with a leading fertility clinic.

Attendees will leave with a better understanding of the process and when and how to deploy design thinking. If you are developing new products and services, looking to enhance patient and clinician experience, solving complex challenges, or looking to drive change this breakfast is a must-attend.

We hope that you can join us for what is sure to be a lively and informative discussion – with complimentary breakfast!

Please register to attend.

Speakers

Craig WillsManaging DirectorHi Mum! Said Dad

Katya ZubarevaPartnerL.E.K. Consulting

Klaus BoehnckePartnerL.E.K. Consulting

Jacqueline ThompsonPartnerL.E.K. Consulting

Getting the most out of your data

How are providers assessing and extracting value from their data? How do you best analyse it to improve outcomes and patient experience? And how do you best analyse it to optimise workflow and patient throughput? Three case studies demonstrate what is possible and the pitfalls to avoid.

Speakers include:

Wolfgang Hofmann, Group Head Technology and Innovation, Fresenius Group
Wolfgang will share how Fresenius is approaching digitalisation, implementing generative AI and moving to the cloud in the complexity of a large organisational structure.
Prof Dr Jörg Debatin, Founder, Honic

Moderated by Alex Beauvais, Partner, McKinsey & Company

Speakers

Prof Dr Jörg DebatinFounderHonic

Alex BeauvaisPartnerMcKinsey & Company

The reawakening of nuclear medicine

Nuclear medicine has long had its place in the diagnosis and treatment of disease, primarily in cardiology and oncology. Today, the nuclear medicine market is at an inflection point, as the rise of theragnostics and the advent of novel products is expected to nearly quadruple the size of the market in the next 10 years from ~$7bn to $25+bn by 2033. The enormous growth in the field is driven by continued radiopharmaceutical funding where 250+ trials are currently being conducted and by trial funding increasing ~45%+ p.a. between 2019 and 2022. This session features perspectives from a provider, radiopharmaceutical group and OEM on how this is accelerating growth, shaping the market and discussing the medium and long-term obstacles.

Moderation and market overview: Ian Poburenny, Director, Rothschild & Co

Speakers include:

Chait Tatineni, CEO International and Chief M&A Officer, Curium
Mark Chapman, CEO, Alliance Medical
Ben Newton, Global Head of Oncology, GE Healthcare

Speakers

Ian PoburennyDirectorRothschild & Co

Chaitanya TatineniCEO International and Chief M&A OfficerCurium

Mark ChapmanCEOAlliance Medical

Ben NewtonGlobal Head of OncologyGE Healthcare